Tango for Neuropathy Among Breast Cancer Survivors
Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Oct 29, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Tango for Neuropathy Among Breast Cancer Survivors," is exploring how group dance classes, specifically tango, can help improve the quality of life and physical health for breast cancer survivors experiencing neuropathy. Neuropathy is a condition that can cause pain, tingling, or numbness, often in the hands and feet. The researchers want to see if dancing in a supportive group setting can enhance both physical abilities, like balance, and emotional well-being for these survivors.
To participate, you need to be a breast cancer survivor who has completed certain chemotherapy treatments at least three months ago and is experiencing symptoms of neuropathy. You should also be able to follow directions during the dance classes. However, if you have certain conditions, like uncontrolled diabetes or specific orthopedic issues, you may not be eligible. Participants can expect to join dance classes that not only focus on movement but also promote social interaction and support. This trial is currently recruiting participants of all ages, and it offers a unique opportunity to potentially improve both physical and emotional health through dance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Breast cancer survivor stage I-III
- • Symptomatic for neuropathy
- • postural control outside 70% CI for adults who are middle-aged without neurotrauma
- • having completed taxane-based chemotherapy treatment at least 3 months ago;
- • able to understand and comply with directions associated with testing and study treatments.
- Exclusion Criteria:
- • Pre-existing vestibular deficit;
- • poorly controlled diabetes (hgA1C \> 8);
- • non-ambulatory or lower extremity amputation (assistive devices allowed);
- • use of cytotoxic or immunotherapy during study (endocrine therapy allowed);
- • participation in physical therapy during the study;
- • contraindication to participate in Tango due to orthopedic issue (e.g., herniated vertebral disc);
About Ohio State University Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Lise Worthen-Chaudhari, PhD, MFA
Principal Investigator
Ohio State University Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials